These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 16881942)

  • 1. Health literacy as a predictor of follow-up after an abnormal Pap smear: a prospective study.
    Lindau ST; Basu A; Leitsch SA
    J Gen Intern Med; 2006 Aug; 21(8):829-34. PubMed ID: 16881942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do follow-up recommendations for abnormal Papanicolaou smears influence patient adherence?
    Melnikow J; Chan BK; Stewart GK
    Arch Fam Med; 1999; 8(6):510-4. PubMed ID: 10575390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer screening in women: body mass index and adherence to physician recommendations.
    Ferrante JM; Chen PH; Crabtree BF; Wartenberg D
    Am J Prev Med; 2007 Jun; 32(6):525-31. PubMed ID: 17533069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.
    Branca M; Garbuglia AR; Benedetto A; Cappiello T; Leoncini L; Migliore G; Agarossi A; Syrjänen K;
    Int J STD AIDS; 2003 Jun; 14(6):417-25. PubMed ID: 12816671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in cervical cancer screening and follow-up for black and white women in the United States.
    Ford S; Tarraf W; Williams KP; Roman LA; Leach R
    Gynecol Oncol; 2021 Feb; 160(2):369-374. PubMed ID: 33323276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knowledge and attitudes as predictors of cervical cancer screening among women in a Venezuelan urban area.
    Núñez-Troconis J; Tulliani E; Gabriela Martínez M; Fernández N
    Invest Clin; 2013 Mar; 54(1):20-33. PubMed ID: 23781710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal Pap smear follow-up in a high-risk population.
    Engelstad LP; Stewart SL; Nguyen BH; Bedeian KL; Rubin MM; Pasick RJ; Hiatt RA
    Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1015-20. PubMed ID: 11588126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervical cancer screening after 50: near extinction?
    Abdullah NN; Daud S; Al-Kubaisy W; Saari IS; Saad SR
    Eur J Obstet Gynecol Reprod Biol; 2016 Nov; 206():136-140. PubMed ID: 27693934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of adherence to follow-up recommendations after an abnormal Pap smear among underserved inner-city women.
    Miller SM; Tagai EK; Wen KY; Lee M; Hui SA; Kurtz D; Scarpato J; Hernandez E
    Patient Educ Couns; 2017 Jul; 100(7):1353-1359. PubMed ID: 28190541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of cervical cancer screening program at a rural community of South Africa.
    Hoque M; Hoque E; Kader SB
    East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of health belief and health literacy with Pap smear practice among Asian immigrant women.
    Eo YS; Kim JS
    Eur J Oncol Nurs; 2019 Oct; 42():63-68. PubMed ID: 31446265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case management intervention in cervical cancer prevention: the Boston REACH coalition women's health demonstration project.
    Clark CR; Baril N; Hall A; Kunicki M; Johnson N; Soukup J; Lipsitz S; Bigby J
    Prog Community Health Partnersh; 2011; 5(3):235-47. PubMed ID: 22080772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The burden of prevention: downstream consequences of Pap smear testing in the elderly.
    Sirovich BE; Gottlieb DJ; Fisher ES
    J Med Screen; 2003; 10(4):189-95. PubMed ID: 14738656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physician recommendation for papanicolaou testing among U.S. women, 2000.
    Coughlin SS; Breslau ES; Thompson T; Benard VB
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1143-8. PubMed ID: 15894664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlates of intent to seek unnecessary pap tests among elderly women.
    Zhang Y; Borders TF; Rohrer JE
    Womens Health Issues; 2007; 17(6):351-9. PubMed ID: 17936642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Educational level and cervical cancer screening programs in a Venezuelan urban area.
    Núñez-Troconis J; Velásquez J; Mindiola R; Munroe D
    Invest Clin; 2008 Sep; 49(3):331-9. PubMed ID: 18846774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The frequency of having pap-smear tests among women between 15-64 years old and the evaluation of the level of their knowledge.
    Sevil S; Kevser O; Aleattin U; Ozlem D
    J Pak Med Assoc; 2013 Jul; 63(7):873-7. PubMed ID: 23901712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast and cervical cancer screening utilization among Hispanic women living near the United States-Mexico border.
    Nuño T; Castle PE; Harris R; Estrada A; García F;
    J Womens Health (Larchmt); 2011 May; 20(5):685-93. PubMed ID: 21428792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Follow up after an abnormal pap smear: time interval acceptable, nature of follow up leaves room for improvement].
    Geertsen M; Bais AG; Beerman H; Helmerhorst TJ
    Ned Tijdschr Geneeskd; 2003 Dec; 147(49):2430-4. PubMed ID: 14694554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barriers to cervical cancer screening in women attending the Family Medical Program in Niterói, Rio de Janeiro.
    Augusto EF; Rosa ML; Cavalcanti SM; Oliveira LH
    Arch Gynecol Obstet; 2013 Jan; 287(1):53-8. PubMed ID: 22886356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.